| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aee32ee4d927c3464c11ae4c41d0b557 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H13-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H13-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H3-06 |
| filingDate |
1993-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685543c3f9914756bff15aa94286805a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41ccb8f067d213ef2df8e3b7e2eff7ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc74968f16500bce2b1d025f117f3a49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a9863bfbfd8c911fab21f45a577fe9c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f32144a178bf93c207d366536deb305c |
| publicationDate |
1994-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9414849-A1 |
| titleOfInvention |
Sulfated polysaccharides as inhibitors of smooth muscle cell proliferation |
| abstract |
Highly sulfated oligosaccharides in the form of hexasaccharide and octasaccharide compounds which have antiproliferative activity with respect to smooth muscle cells are useful in treatment of coditions characterized by unwanted smooth muscle cell proliferation such as a result of trauma or disease states such as asthma, congestive heart failure and hypertension. The oligosaccharides have increased ability to inhibit the proliferation of smooth muscle cells and decreased ability to act as an anticoagulant as compared with commercial heparin and/or unseparated fragments of heparin. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006017726-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7902158-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8987216-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006017726-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0717995-A2 |
| priorityDate |
1992-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |